Related Experiment Video
Updated: Jun 24, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
Parkinson's disease: convergence on synaptic homeostasis
Sandra-Fausia Soukup1,2, Roeland Vanhauwaert3,2, Patrik Verstreken1,2
1VIB-KU Leuven Center for Brain& Disease Research, Leuven, Belgium sandra.soukup@kuleuven.vib.be patrik.verstreken@kuleuven.vib.be.
The EMBO Journal
|August 2, 2018
Summary
Parkinson's disease involves synaptic defects, where Parkinson proteins regulate endocytosis and autophagy. Loss of synaptic balance contributes to neurodegeneration in this common disorder.
Area of Science:
- Neuroscience
- Neurodegenerative Disorders
- Cell Biology
Background:
- Parkinson's disease (PD) is a prevalent neurodegenerative disorder affecting millions worldwide.
- Its prevalence is projected to double by 2030, highlighting an urgent need for understanding disease mechanisms.
- Over half of identified PD risk factors and causative genes are linked to synaptic function.
Purpose of the Study:
- To review recent findings on the role of Parkinson's disease proteins at the synapse.
- To propose a model for how these proteins interact within specific cell compartments.
- To elucidate the mechanisms underlying synaptic dysfunction in Parkinson's disease pathogenesis.
Main Methods:
- Review of current scientific literature on Parkinson's disease genetics and synaptic function.
- Analysis of protein interactions within distinct synaptic compartments.
- Integration of data to propose a mechanistic model of neurodegeneration.
Main Results:
- Identified numerous Parkinson's disease genes and risk factors, with over 50% impacting synaptic function.
- Proposed a model where Parkinson proteins interact specifically within synaptic compartments.
- Highlighted the roles of endocytosis and autophagy regulation by these proteins at the synapse.
Conclusions:
- Synaptic defects, particularly in endocytosis and autophagy, are early events in Parkinson's disease.
- Dysfunctional synaptic homeostasis driven by Parkinson proteins contributes significantly to neurodegeneration.
- Understanding these synaptic mechanisms is crucial for developing future Parkinson's disease therapies.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...